Controversies in Liver Transplantation
Supported by an Unrestricted Educational Grant from Astellas

8:00 – 8:05 am

Hepatitis C Virus (HCV)

HCV: Scope of the Problem—Present and Future Therapies
Gregory T. Everson, MD

Pretransplant Management of the Wait-List Patient
Xavier Forns, MD, PhD

Donor and Peritransplant Factors in HCV Outcome
R. Mark Ghobrial, MD, PhD

Immunobiology of HCV Recurrence
Geoff McCaughan, MD, PhD

Current Results of Transplantation for HCV and Predictors of Outcome
John R. Lake , MD

Impact of Immunosuppression on HCV
John O'Grady, MD

Comparison of Live Donor Versus Deceased Donor Transplant for HCV
Ronald W. Busuttil, MD, PhD

Discussion

Liver Transplantation for Co-infected HIV Patients
Nigel Heaton, MD

Extrahepatic Complications of HCV Posttransplant
Didier Samuel, MD

Strategies to Prevent and Treat Recurrent HCV Infection
Michael R. Charlton, MD

HEPATOCELLULAR CARCINOMA ( HCC )

HCC in Cirrhosis: Scope of the Problem
Myron J. Tong, MD, PhD

Diagnostic Workup for HCC Patients
Richard B. Freeman, MD

Role of Ablative Therapy for HCC in Transplant Candidates
Masao Omata, MD

Liver Transplantation for HCC
Western Perspective: John P. Roberts, MD
Asian Perspective: Yasuhiko Sugawara , MD

Debate: Is Resection a Suitable Bridge in the Transplant Candidate?
Pro: Rene Adam, MD
Con: Jacques Belghiti, MD  

OLT for Hepatoblastoma
Douglas G. Farmer, MD

OLT for Cholangiocarcinoma
Peter Neuhaus, MD, PhD

New and Future Therapies for HCC
Adrian Di Bisceglie, MD

Future Evolution
Ronald W. Busuttil, MD, PhD